# Dokkyo Medical University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/dokkyo-medical-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 51.3 |
| Citations | 392,513 |
| City | Mibu |
| Country | JP |
| Description | Dokkyo Medical University is a research organisation in Mibu, JP. OpenAlex records 10,075 works and 392,513 citations for it. 2,545 researchers list it as their most recent affiliation. |
| Homepage | https://www.dokkyomed.ac.jp |
| OpenAlex ID | https://openalex.org/I78274823 |
| Researchers | 2,545 |
| ROR ID | https://ror.org/05k27ay38 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q687942 |
| Works | 10,075 |

## University papers

Showing 12 of 33.

- [Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/dacomitinib-versus-gefitinib-as-first-line-treatment-for-patients-with-egfr/)
- [A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study](https://scholariq.org/papers/a-single-question-screen-for-rapid-eye-movement-sleep-behavior-disorder-a/)
- [Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and <i>EGFR</i>-Activating Mutations](https://scholariq.org/papers/improvement-in-overall-survival-in-a-randomized-study-that-compared-dacomitinib/)
- [Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study](https://scholariq.org/papers/risk-factors-for-neurodegeneration-in-idiopathic-rapid-eye-movement-sleep/)
- [Reduced cardiac <sup>123</sup> I-MIBG scintigraphy in idiopathic REM sleep behavior disorder](https://scholariq.org/papers/reduced-cardiac-sup-123-sup-i-mibg-scintigraphy-in-idiopathic-rem-sleep-behavior/)
- [Sleep disorders in the elderly: Diagnosis and management](https://scholariq.org/papers/sleep-disorders-in-the-elderly-diagnosis-and-management/)
- [Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis](https://scholariq.org/papers/therapeutic-priority-of-the-pi3k-akt-mtor-pathway-in-small-cell-lung-cancers-as/)
- [Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer](https://scholariq.org/papers/randomized-phase-ii-study-of-first-line-carboplatin-paclitaxel-with-or-without/)
- [Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial](https://scholariq.org/papers/lenvatinib-in-patients-with-advanced-or-metastatic-thymic-carcinoma-remora-a/)
- [Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung](https://scholariq.org/papers/genomic-profiling-of-large-cell-neuroendocrine-carcinoma-of-the-lung/)
- [First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study](https://scholariq.org/papers/first-line-single-agent-treatment-with-gefitinib-in-patients-with-advanced-non/)
- [Combination Chemotherapy with Irinotecan and Cisplatin for Large-Cell Neuroendocrine Carcinoma of the Lung: A Multicenter Phase II Study](https://scholariq.org/papers/combination-chemotherapy-with-irinotecan-and-cisplatin-for-large-cell/)

## University researchers

- [Seiji Niho](https://scholariq.org/researchers/seiji-niho/)
- [Masayuki Miyamoto](https://scholariq.org/researchers/masayuki-miyamoto/)
- [Takahiro Jimbo](https://scholariq.org/researchers/takahiro-jimbo/)

## University top topics

Showing 8 of 25.

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Spine and Intervertebral Disc Pathology](https://scholariq.org/topics/spine-and-intervertebral-disc-pathology/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.